PEPTIDE RESEARCH TOPIC

TB-500 Research Peptide

Browse TB-500 research information, thymosin beta-4 terminology, product identity, storage, and comparisons.

TOPIC OVERVIEW

About TB-500

Identity and names

TB-500 is a commercial and research label associated with thymosin beta-4-related peptide material.

  • TB 500 and TB500 are spelling variants, but full-length thymosin beta-4, TB-500, and a TB4 fragment should not be treated as automatic synonyms.

Compound type

Full-length thymosin beta-4 is a 43-amino-acid actin-binding peptide.

  • Products sold as TB-500 may use a fragment or another related sequence, making molecular mass and sequence data essential to identity.

Mechanism

Thymosin beta-4 research examines G-actin binding, cytoskeletal organization, cell migration, angiogenesis, inflammation, and tissue-repair models.

  • Evidence for the full-length peptide cannot be transferred automatically to a fragment, modified sequence, or differently formulated material.

Research focus and evidence

Most promoted applications are supported mainly by cell and animal research rather than robust controlled human trials.

  • This category therefore emphasizes sequence distinctions, experimental models, analytical identity, stability, and evidence limitations.

Regulatory status and limits

TB-500 is not generally approved as a therapeutic medicine, and thymosin beta-4 and its derivatives are prohibited in sport under current World Anti-Doping Agency rules.

  • Ambiguous product names add uncertainty about identity, purity, sterility, concentration, and the relevance of any cited study.
Topics covered
  • TB-500 and thymosin beta-4
  • sequence and identity distinctions
  • preclinical research context
  • storage and handling
  • COA and purity questions
Common names and related terms: tb-500, tb 500, tb500, thymosin beta-4
EVIDENCE PROFILE

TB-500 Research Evidence

A concise view of registered clinical research, PubMed-indexed literature, evidence stage, and important limitations.

LAST VERIFIEDSeptember 30, 2026
Registered records1
Active studies1
Completed studies0
PubMed records28
Compound typeSynthetic peptide associated with thymosin beta-4
AliasesThymosin beta-4 fragment
Evidence stageVery limited registered clinical evidence; related-compound literature requires careful separation
U.S. regulatory contextNot FDA-approved
CLINICAL REGISTRY

Selected registered research

NCT07487363Phase 1 / Phase 2 · Recruiting

TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD

INDEXED LITERATURE

Selected PubMed records

PMID 414764242026 Jan · The American journal of sports medicine

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.

PMID 414902002026 Jan 1 · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

PMID 419666392026 Aug · Sports medicine (Auckland, N.Z.)

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

How to interpret this profile

Registry and publication counts describe discoverable records, not proof of effectiveness or safety. Study design, compound identity, population, endpoints, and regulatory context must be reviewed individually.

Primary sources: ClinicalTrials.gov · PubMedCounts are dated exact-term search snapshots, not evidence-quality scores. Related compounds, spelling variants, and non-indexed literature may not be included.

Displayed records are selected for relevance and recency; the page does not reproduce the complete source databases.

START HERE

Essential TB-500 guides

TB-500 KNOWLEDGE ARTICLESPage 1 of 7
04
KNOWLEDGE ARTICLE

TB-500 Oral vs Injectable: Which Works Better?

TB-500 oral vs injectable: compare bioavailability, dosing, and cost. Learn why injections dominate research use and what oral capsules can actually deliver.

↗
05
KNOWLEDGE ARTICLE

Penguin Peptides TB-500: What Buyers Should Know

Penguin Peptides TB-500 is a research-only thymosin beta-4 fragment. Learn what the product is, how researchers handle dosing, purity checks, and safety.

↗
06
KNOWLEDGE ARTICLE

Thymosin Beta 4 vs TB-500: Key Differences

Thymosin beta 4 vs TB-500: are they the same peptide? Learn how TB-500 relates to thymosin beta-4, plus research on dosing, safety, and legality.

↗
08
KNOWLEDGE ARTICLE

Wolverine Peptide Stack: What It Is and Safety

The Wolverine peptide stack typically combines BPC-157 and TB-500 for recovery research. Learn what it is, how it's studied, and why it's not FDA-approved.

↗
10
KNOWLEDGE ARTICLE

CJC-1295, BPC-157 & TB-500 Peptide Guide

CJC-1295, BPC-157, and TB-500 explained: how each peptide works, how they differ, safety concerns, and why none is FDA-approved for human use.

↗
11
KNOWLEDGE ARTICLE

Pinnaclepeptides: What to Know Before You Buy

Pinnaclepeptides is a research peptide vendor selling BPC-157, TB-500 and retatrutide. See what buyers should verify, plus safety and legal facts.

↗
15
KNOWLEDGE ARTICLE

BPC-157 and TB-500 for Back Pain: What to Know

BPC-157 and TB-500 for back pain is a popular peptide combo in recovery circles. Learn how they work, dosing research, safety, and legal status.

↗
16
KNOWLEDGE ARTICLE

BPC-157 TB-500 Transdermal Gel: What to Know

BPC-157 TB-500 transdermal gel is a topical research peptide blend. Learn how it's marketed, what the evidence says, dosing claims, and safety limits.

↗
17
KNOWLEDGE ARTICLE

Are Peptides Safe to Take for Muscle Growth?

Are peptides safe to take for muscle growth? Learn what research says about BPC-157, TB-500, and growth hormone peptides, plus legal and safety concerns.

↗